Has Martha St John, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,722 in general payments to Martha St John, MD across 311 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Martha St John, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Martha St John, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Martha St John, MD

Psychiatry · Houston, TXNPI 1073534921

Payments from drug & device makers

$6,722in general payments, 2019–2025

Across 311 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$971
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$969
Takeda Pharmaceuticals U.S.A., Inc.$649
Otsuka America Pharmaceutical, Inc.$632
Corium, LLC$394
Johnson & Johnson$379
plus $3K from 23 others

What the payments were for

Food & beverage$6,700100%
Education$230%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	60	$971
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	42	$969
Takeda Pharmaceuticals U.S.A., Inc.	34	$649
Otsuka America Pharmaceutical, Inc.	26	$632
Corium, LLC	16	$394
Johnson & Johnson	15	$379
Bausch Health US, LLC	18	$372
Lundbeck LLC	15	$333
Alkermes, Inc.	10	$226
Novo Nordisk	2	$217
Noven Therapeutics, LLC	11	$214
Axsome Therapeutics, Inc.	6	$161
Idorsia Pharmaceuticals US Inc	7	$154
Vanda Pharmaceuticals Inc.	7	$130
Medtronic	1	$122
Neos Therapeutics, LP	6	$109
Neurocrine Biosciences, Inc.	4	$106
E.r. Squibb & Sons, L.L.C.	4	$93
Ironshore Pharmaceuticals Inc.	5	$88
Supernus Pharmaceuticals, Inc.	3	$63
Adlon Therapeutics L.p.	3	$61
Vertical Pharmaceuticals, LLC	3	$47
Livanova USA, Inc.	2	$45
Avanir Pharmaceuticals, Inc.	2	$41
Shire North American Group Inc	2	$36
Teva Pharmaceuticals USA, Inc.	2	$33
Neuronetics, Inc.	3	$32
Jazz Pharmaceuticals Inc.	1	$23
Tris Pharma Inc	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,722 in reported general payments places this provider in the 85th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas →

Medicare billing

Part B allowed, 2024

$167,202

Medicare patients

Services billed

376

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ziprasidone Hcl	16	$3,496
Bupropion XlBupropion Hcl	41	$1,275
Duloxetine Hcl	51	$1,223
Quetiapine Fumarate	18	$948
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	31	$815
Lamotrigine	26	$762
Fluoxetine Hcl	31	$675
Clonazepam	103	$646
Venlafaxine Hcl ErVenlafaxine Hcl	21	$586
Buspirone Hcl	22	$414
Escitalopram Oxalate	21	$394
Paroxetine Hcl	24	$281
Mirtazapine	24	$247
Trazodone Hcl	34	$247
Sertraline Hcl	15	$201

Paid to pharmacies, not to this prescriber.

Other psychiatry in Houston

Matthew BramsHouston$3M
Lawrence GinsbergHouston$2.4M
Asim ShahHouston$2.2M
Aqeel HashmiHouston$1.3M
Robert EarleHouston$1.1M
Frank ChenHouston$941K
Joao de QuevedoHouston$890K
Alice MaoHouston$850K
Mazhar KhowajaHouston$843K
Barry GritzHouston$792K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →